TopGum expands gut health gummy supplement range

TopGum Industries has introduced an expanded range of gut health gummy supplements, combining probiotic, prebiotic and postbiotic ingredients with its Gummiceuticals fibre-based sweetening platform for companies developing branded nutrition products.

Announced on 13 October 2026, the collection includes an Akkermansia formulation developed with The Akkermansia Company, a high-fibre product called FiberMaxxing and additional gummies combining ingredients associated with microbiome-related supplement applications.

The products use natural fruit flavours and contain no added sugar, according to the manufacturer. TopGum plans to introduce the collection at SupplySide Global 2026 in Las Vegas, where it will demonstrate the formulations to supplement brands and other industry visitors.

Developing these products involves balancing functional ingredient content with the processing and sensory requirements of a gummy. Active ingredients must remain within their specified limits while the finished piece achieves the required texture, appearance and stability.

Traditional gummy confectionery depends on a combination of sweeteners, water, gelling ingredients and processing conditions to develop its structure. Changes to any of these components can affect viscosity during manufacture and the firmness or elasticity of the finished product.

TopGum’s Gummiceuticals system uses a fibre-based sweetening approach incorporating ingredients derived from chicory, including fructo-oligosaccharides. The company employs this matrix to replace conventional added sugars while accommodating functional ingredients within a chewable format.

Fibre-based formulations can present different manufacturing characteristics from conventional sugar systems. Some fibres absorb substantial quantities of water, changing the behaviour of the mixture during heating, blending, depositing and setting.

Viscosity is particularly important when a gummy mixture must pass through equipment designed to dispense consistent portions into individual moulds. A material that becomes too viscous may be difficult to deposit accurately, while changes in gel formation can affect the finished product’s dimensions and texture.

The new Akkermansia gummy contains 10 billion total fluorescence units, or TFU, of Akkermansia muciniphila TAC-01, a branded ingredient developed by The Akkermansia Company. The formulation primarily targets the North American market.

The bacterial material is pasteurised rather than supplied as a conventional live probiotic preparation. This distinction affects how the ingredient is described and measured, as well as the characteristics that must be maintained during processing and storage.

Total fluorescence units are not directly interchangeable with colony-forming units, or CFU, commonly used to describe viable microorganisms. Comparing two ingredients using these different measurements requires an understanding of the analytical methods and what each specification represents.

TopGum has incorporated the Akkermansia ingredient into a pineapple-flavoured gummy using chicory fructo-oligosaccharides as part of the sweetening system. The manufacturer says the formulation is intended to protect the ingredient while providing a consistent dose in a single piece.

The commercial formulation must maintain the specified ingredient content while achieving the required eating characteristics. Product consistency depends on the preparation and distribution of the ingredient throughout the gummy mixture, as well as subsequent handling and storage.

TopGum associates Akkermansia with possible metabolic and microbiome-related benefits, but the claims made about an ingredient must be distinguished from independently demonstrated effects of the finished supplement. The company’s announcement does not establish that its new gummy has received authorisation for particular health claims in every market.

The range also includes FiberMaxxing, a 4.5g berry-flavoured gummy incorporating 2.5g of soluble and insoluble fibre. This represents a substantial proportion of the finished unit and creates formulation challenges associated with water absorption, material handling and texture.

Fibre can influence how a mixture flows before setting and how the finished gummy behaves when chewed. Its particle characteristics, hydration behaviour and interactions with other formulation components affect the potential for graininess, excessive firmness or inconsistent texture.

TopGum says the FiberMaxxing formulation incorporates the additional fibre while retaining an acceptable gummy structure. The announcement does not provide comparative instrumental texture measurements or the processing conditions used to achieve that result.

Achieving a specified fibre quantity within an individual piece also requires suitable control of depositing and ingredient distribution. Variation between gummies can affect the amount delivered in a serving, making formulation consistency part of the finished product specification.

The collection includes a synbiotic formulation combining prebiotic material with Bacillus subtilis DE111 and an additional postbiotic ingredient. TopGum specifies one billion CFU of DE111 and 20mg of LP20, alongside chicory-derived fructo-oligosaccharides.

Live microorganisms create different processing requirements from pasteurised bacterial preparations. Their viability may be affected by temperature, acidity, water activity and the duration of processing or storage, depending on the organism and its characteristics.

Spore-forming organisms can provide advantages in selected formulations because dormant spores may tolerate conditions that would damage more sensitive microbial preparations. Their use still requires verification of the finished ingredient count and stability under the intended manufacturing and storage conditions.

TopGum previously introduced a synbiotic gummy incorporating Bacillus subtilis and other microbiome-related ingredients. The October collection therefore represents an extension of its established formulation capabilities, rather than the company’s first use of probiotic or prebiotic technology in gummies.

Another formulation in the new range combines cranberry extract with Bacillus coagulans for women’s health applications. The company presents the product as a supplement concept, with any permitted ingredient and health claims dependent on the requirements of the market in which it is sold.

Different ingredients may require separate analytical methods to verify identity, content and stability. A finished gummy containing live microorganisms, a botanical extract and prebiotic fibre cannot necessarily be assessed using the same controls as a formulation containing only a pasteurised bacterial preparation.

Manufacturers also need to consider changes in ingredient properties over the intended shelf life. Moisture movement, storage temperature and interactions between ingredients can alter the finished product, potentially affecting texture or the quantity of a specified component remaining available at the end of storage.

Packaging selection forms part of that assessment because barrier properties and storage conditions influence exposure to moisture and other environmental factors. The appropriate packaging specification depends on the stability requirements of the particular formulation rather than the gummy format alone.

TopGum’s expanded range provides supplement brands with additional formulations built around its existing sweetening platform. The company has not disclosed production volumes, individual customer contracts or commercial sales commitments associated with the new collection.

The products will be presented at SupplySide Global 2026, with the manufacturing challenge centred on reproducing the required ingredient content and physical characteristics across commercial batches. Further evidence of stability, customer adoption and finished product performance will be needed to establish the results achieved by each formulation.